Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EC50 of ropivacaine with or without dexmedetomidine for supra-inguinal fascia iliaca compartment block analgesia
ChiCTR2300068169Phase 4Not yet recruiting
- Sponsor
- Funing County People's Hospital
- Start
- Feb 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ropivacaine and dexmedetomidine in postoperative pain (4 arms), sponsored by Funing County People's Hospital. Primary endpoints: Visual analogue scale score and Half effective concentration (EC50) by sequential approach. Planned start Feb 2023; status: not yet recruiting.
02
Drugs
ropivacainedexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2300068169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300068169.